rs146057680
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4BS1_Supporting
The NM_001482.3(GATM):c.701A>G(p.Asp234Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000248 in 1,614,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001482.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATM | NM_001482.3 | c.701A>G | p.Asp234Gly | missense_variant | Exon 5 of 9 | ENST00000396659.8 | NP_001473.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000191 AC: 48AN: 251340Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135842
GnomAD4 exome AF: 0.000253 AC: 370AN: 1461816Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 176AN XY: 727204
GnomAD4 genome AF: 0.000204 AC: 31AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74344
ClinVar
Submissions by phenotype
not provided Uncertain:1Other:1
Published functional studies demonstrate no damaging effect (DesRoches et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27233232) -
- -
Inborn genetic diseases Uncertain:1
The p.D234G variant (also known as c.701A>G), located in coding exon 5 of the GATM gene, results from an A to G substitution at nucleotide position 701. The aspartic acid at codon 234 is replaced by glycine, an amino acid with similar properties. In an assay of GATM activity this alteration was found to be functionally normal (DesRoches CL et al. Hum. Mutat., 2016 09;37:926-32). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Arginine:glycine amidinotransferase deficiency Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 234 of the GATM protein (p.Asp234Gly). This variant is present in population databases (rs146057680, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with GATM-related conditions. ClinVar contains an entry for this variant (Variation ID: 205624). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GATM protein function. Experimental studies have shown that this missense change does not substantially affect GATM function (PMID: 27233232). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Arginine:glycine amidinotransferase deficiency;C4551503:Fanconi renotubular syndrome 1 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at